PILOT AND FEASIBILITY GRANT PROGRAM: ABSTRACT The DRC P&F Grant Program has several goals. First is to enrich the scientific base of the DRC at Joslin and other local institutions. Another major goal is to enhance interactions between researchers at Joslin and other local institutions, and in particular to enhance interactions between basic and clinical researchers focused on diabetes and its complications. Finally, the DRC P&F Program aims to enhance research into the pathogenesis, treatments and potential cures for all types of diabetes and their complications more generally. Critical for the achievement of these goals is recruiting talented new investigators and embracing promising new experimental strategies or methods. Therefore, the program has traditionally provided support to three types of researchers: 1. New investigators in the diabetes field who have not previously received substantial NIH funding; 2. Experienced investigators in the diabetes field who wish to strike out in a novel direction; and 3. Investigators from other fields embarking on a diabetes-related project for the first time. To accomplish this we hold a yearly competitive application process. Several months before the submission deadline we announce the upcoming P&F grant opportunity as broadly as possible to eligible departments and institutions. Applicants are asked to submit a description (abstract) of the proposed project using the designated website. Applications that are eligible are invited to submit a full proposal. Full proposals are judged by internal and external reviewers chosen on the basis of expertise. We utilize a nationwide network of experts in the various fields related to diabetes to identify appropriate reviewers. Proposals receiving the highest scores are recommended for funding to begin Jan 1 of the subsequent year. Anonymous reviews are provided to the applicants. We try to integrate P&F grant recipients, within Joslin and from other institutions, by encouraging use of the DRC cores and facilities. P&F grant recipients are also asked to present the results of their P&F projects during a Joslin seminar and to attend Joslin's research retreat. Each investigator is asked to demonstrate progress on the project in order to justify a second year of support, and a final report is required at the end of the funding period. The Joslin diabetes Center DRC P&F Grant Program has been highly successful for over 30 years.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK036836-33
Application #
9701966
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2019-04-01
Budget End
2020-03-31
Support Year
33
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Joslin Diabetes Center
Department
Type
DUNS #
071723084
City
Boston
State
MA
Country
United States
Zip Code
02215
Srinivasan, Shylaja; Kaur, Varinderpal; Chamarthi, Bindu et al. (2018) TCF7L2 Genetic Variation Augments Incretin Resistance and Influences Response to a Sulfonylurea and Metformin: The Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH). Diabetes Care 41:554-561
Goldford, Joshua E; Lu, Nanxi; Baji?, Djordje et al. (2018) Emergent simplicity in microbial community assembly. Science 361:469-474
Karst, Sonja G; Lammer, Jan; Radwan, Salma H et al. (2018) Characterization of In Vivo Retinal Lesions of Diabetic Retinopathy Using Adaptive Optics Scanning Laser Ophthalmoscopy. Int J Endocrinol 2018:7492946
Soto, Marion; Orliaguet, Lucie; Reyzer, Michelle L et al. (2018) Pyruvate induces torpor in obese mice. Proc Natl Acad Sci U S A 115:810-815
Kim, Youngjo; Bayona, Princess Wendy; Kim, Miri et al. (2018) Macrophage Lamin A/C Regulates Inflammation and the Development of Obesity-Induced Insulin Resistance. Front Immunol 9:696
Espeland, Mark A; Carmichael, Owen; Hayden, Kathleen et al. (2018) Long-term Impact of Weight Loss Intervention on Changes in Cognitive Function: Exploratory Analyses from the Action for Health in Diabetes Randomized Controlled Clinical Trial. J Gerontol A Biol Sci Med Sci 73:484-491
Aguayo-Mazzucato, Cristina; Bonner-Weir, Susan (2018) Pancreatic ? Cell Regeneration as a Possible Therapy for Diabetes. Cell Metab 27:57-67
Mulla, Christopher M; Middelbeek, Roeland J W; Patti, Mary-Elizabeth (2018) Mechanisms of weight loss and improved metabolism following bariatric surgery. Ann N Y Acad Sci 1411:53-64
Skupien, Jan; Smiles, Adam M; Valo, Erkka et al. (2018) Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy. Diabetes Care :
Laffel, L (2018) Lost in transition: finding a path forward for young adults with Type 1 diabetes. Diabet Med 35:1061-1062

Showing the most recent 10 out of 1120 publications